JP2024523876A5 - - Google Patents
Info
- Publication number
- JP2024523876A5 JP2024523876A5 JP2023577376A JP2023577376A JP2024523876A5 JP 2024523876 A5 JP2024523876 A5 JP 2024523876A5 JP 2023577376 A JP2023577376 A JP 2023577376A JP 2023577376 A JP2023577376 A JP 2023577376A JP 2024523876 A5 JP2024523876 A5 JP 2024523876A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- pharmaceutical product
- product according
- nri
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163211673P | 2021-06-17 | 2021-06-17 | |
| US63/211,673 | 2021-06-17 | ||
| US202263319035P | 2022-03-11 | 2022-03-11 | |
| US63/319,035 | 2022-03-11 | ||
| PCT/US2022/033987 WO2022266440A1 (en) | 2021-06-17 | 2022-06-17 | Norepinephrine reuptake inhibitors for treating sleep apnea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523876A JP2024523876A (ja) | 2024-07-02 |
| JP2024523876A5 true JP2024523876A5 (https=) | 2025-06-24 |
Family
ID=82608262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577376A Pending JP2024523876A (ja) | 2021-06-17 | 2022-06-17 | 睡眠時無呼吸を治療するためのノルエピネフリン再取り込み阻害剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240277719A1 (https=) |
| EP (1) | EP4355333A1 (https=) |
| JP (1) | JP2024523876A (https=) |
| KR (1) | KR20240021920A (https=) |
| AU (1) | AU2022294086A1 (https=) |
| BR (1) | BR112023026158A2 (https=) |
| CA (1) | CA3221848A1 (https=) |
| IL (1) | IL309251A (https=) |
| MX (1) | MX2023014709A (https=) |
| WO (1) | WO2022266440A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025106773A1 (en) * | 2023-11-17 | 2025-05-22 | Apnimed, Inc. (Delaware) | Methods and compositions for treating sleep apnea with a combination of a glp-1 agonist and a second active agent |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US20060039866A1 (en) * | 2004-08-20 | 2006-02-23 | Cypress Bioscience, Inc. | Method for treating sleep-related breathing disorders |
| EP2167096A4 (en) * | 2007-06-13 | 2010-07-14 | Cypress Bioscience Inc | IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM |
| GEAP202416602A (en) * | 2017-04-28 | 2024-10-10 | Brigham & Womens Hospital Inc | Methods and compositions for treating sleep apnea |
| KR102874891B1 (ko) * | 2018-01-30 | 2025-10-21 | 애프니메드, 인코포레이티드 (델라웨어) | 수면 무호흡증을 치료하기 위한 방법 및 조성물 |
| MX2021004883A (es) * | 2018-10-31 | 2021-08-05 | Apnimed Inc Delaware | Metodos y composiciones para tratar apnea del sue?o. |
| CN118557736A (zh) * | 2019-02-08 | 2024-08-30 | 布里格姆妇女医院 | 用于治疗睡眠呼吸暂停的方法和组合物 |
| US20220362221A1 (en) * | 2019-11-04 | 2022-11-17 | Apnimed, Inc. (Delaware) | Combination pharmacological interventions for multiple mechanisms of obstructive sleep apnea |
| US20240075035A1 (en) * | 2021-01-14 | 2024-03-07 | Apnimed, Inc. (Delaware) | Methods and compositions for treating sleep apnea |
-
2022
- 2022-06-17 US US18/570,673 patent/US20240277719A1/en active Pending
- 2022-06-17 IL IL309251A patent/IL309251A/en unknown
- 2022-06-17 JP JP2023577376A patent/JP2024523876A/ja active Pending
- 2022-06-17 CA CA3221848A patent/CA3221848A1/en active Pending
- 2022-06-17 EP EP22743989.0A patent/EP4355333A1/en active Pending
- 2022-06-17 AU AU2022294086A patent/AU2022294086A1/en active Pending
- 2022-06-17 WO PCT/US2022/033987 patent/WO2022266440A1/en not_active Ceased
- 2022-06-17 MX MX2023014709A patent/MX2023014709A/es unknown
- 2022-06-17 BR BR112023026158A patent/BR112023026158A2/pt unknown
- 2022-06-17 KR KR1020247001376A patent/KR20240021920A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023139000A5 (https=) | ||
| FI3746126T3 (fi) | Menetelmiä ja koostumuksia uniapnean tai pelkän kuorsauksen hoitamiseksi | |
| ES2222522T3 (es) | Tratamiento de la migraña utilizando metoclopramida y un nsaid. | |
| ES2378255T3 (es) | Titulación de tapentadol | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| WO2014020155A1 (en) | Oral transmucosal adminstration forms of s-ketamine | |
| JP2021120379A5 (https=) | ||
| CN107260695A (zh) | 硝唑尼特的控制释放药物剂型 | |
| TW200412934A (en) | Pharmaceutical formulations of modafinil | |
| JP2006506378A5 (https=) | ||
| WO2006023703A2 (en) | Method for treating sleep related breathing disorders | |
| CA2665841A1 (en) | Pharmaceutical compositions | |
| AU2011231645A2 (en) | Fast dissolving drug delivery systems | |
| JP2009508854A (ja) | 睡眠時呼吸障害の予防及び治療方法及び手段 | |
| JP2025084754A5 (https=) | ||
| CN107519159A (zh) | 复方组合物 | |
| CN100558358C (zh) | 唑尼沙胺在制备用于治疗或预防阻塞性睡眠呼吸暂停的药物中的应用 | |
| BR112019027286B1 (pt) | Composição de dissolução oral de melatonina com agente acidificante que torna melatonina solúvel em saliva | |
| CA2870130A1 (en) | Compositions and methods for treating cough | |
| TWI820673B (zh) | 布瑞哌唑口溶膜組合物、其製備方法及用途 | |
| CN102805746B (zh) | 一种作用于呼吸系统疾病的复方化学药及其制备工艺与应用 | |
| CN1154495C (zh) | 米氮平用于治疗睡眠性呼吸暂停的用途 | |
| JP2024523876A5 (https=) | ||
| JP2022177119A5 (https=) | ||
| JP2023521492A5 (https=) |